当前位置: 首页 > 新闻资讯 > 产品文献 > "酶免"产品文献：Impact of supplementing Limosilactobacillus fermentum MN–LF23 on the eradication of Helicobacter pylori with 14–day standard quadruple therapy: a randomized, double–blind, placebo–controlled trial

"酶免"产品文献：Impact of supplementing Limosilactobacillus fermentum MN–LF23 on the eradication of Helicobacter pylori with 14–day standard quadruple therapy: a randomized, double–blind, placebo–controlled trial

酶免官方商城 / 2026-10-09

文献标题

Impact of supplementing Limosilactobacillus fermentum MN–LF23 on the eradication of Helicobacter pylori with 14–day standard quadruple therapy: a randomized, double–blind, placebo–controlled trial

文献作者

Yuyang Zhao、Xiaokang Niu、Yong Zhang、Liang Zhao、Liwei Zhang、Jingjing He、Qi Zhang、Yuejian Mao、Fuqing Wang、Xiaohui Zhao、Ran Wang

发表时间

2025年07月07日

文献影响因子

3.8

使用的酶免科研试剂盒产品名称

人白细胞介素1β（IL-1β）ELISA科研试剂盒

人肿瘤坏死因子α（TNF-α）ELISA科研试剂盒